bf/NASDAQ:DICE_icon.jpeg

NASDAQ:DICE

DICE Therapeutics, Inc.

  • Stock

USD

Last Close

47.52

08/08 20:00

Market Cap

2.27B

Beta: -

Volume Today

4.33M

Avg: 534.33K

PE Ratio

−23.17

PFCF: −26.04

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
net income
-12.94M
-
-23.74M
83.48%
-48.96M
106.24%
-83.89M
71.34%
depreciation and amortization
706K
-
697K
1.27%
661K
5.16%
2.42M
266.57%
deferred income tax
1.67M
-
stock based compensation
529K
-
556K
5.10%
5.58M
903.78%
12.82M
129.80%
change in working capital
-4.65M
-
1.66M
135.77%
1.65M
0.96%
2.64M
60.47%
accounts receivables
1.50M
-
inventory
accounts payables
289K
-
1.41M
388.24%
-772K
154.71%
1.33M
272.80%
other working capital
-4.94M
-
252K
105.10%
2.42M
859.92%
-191K
107.90%
other non cash items
54K
-
144K
166.67%
107K
25.69%
1.67M
1,464.49%
net cash provided by operating activities
-16.30M
-
-20.68M
26.88%
-39.29M
90.01%
-64.32M
63.70%
investments in property plant and equipment
-981K
-
-148K
84.91%
-718K
385.14%
-2.24M
211.56%
acquisitions net
purchases of investments
-39.77M
-
-3.65M
90.83%
-218.47M
5,887.15%
-139.25M
36.26%
sales maturities of investments
21.62M
-
21.80M
0.81%
14.56M
33.19%
228.98M
1,472.10%
other investing activites
net cash used for investing activites
-19.13M
-
18.00M
194.10%
-204.62M
1,236.61%
87.49M
142.76%
debt repayment
-278K
-
-122K
56.12%
-99K
18.85%
-2.64M
2,570.71%
common stock issued
214.71M
-
323.71M
50.77%
common stock repurchased
dividends paid
other financing activites
54.02M
-
85.65M
58.55%
1.19M
98.62%
net cash used provided by financing activities
-278K
-
53.90M
19,486.69%
300.25M
457.11%
322.25M
7.33%
effect of forex changes on cash
net change in cash
-35.71M
-
51.22M
243.44%
56.34M
9.99%
345.42M
513.12%
cash at beginning of period
44.33M
-
8.62M
80.56%
59.84M
594.39%
116.17M
94.15%
cash at end of period
8.62M
-
59.84M
594.39%
116.17M
94.15%
461.59M
297.33%
operating cash flow
-16.30M
-
-20.68M
26.88%
-39.29M
90.01%
-64.32M
63.70%
capital expenditure
-981K
-
-148K
84.91%
-718K
385.14%
-2.24M
211.56%
free cash flow
-17.28M
-
-20.83M
20.53%
-40.01M
92.11%
-66.56M
66.36%

All numbers in USD (except ratios and percentages)